Luszczki J J, Jankiewicz K, Jankiewicz M, Czuczwar S J
Department of Pathophysiology, Medical University of Lublin, Lublin, Poland.
J Neural Transm (Vienna). 2007;114(12):1539-45. doi: 10.1007/s00702-007-0795-4. Epub 2007 Aug 24.
Accumulating evidence indicates that aminophylline [theophylline(2) x ethylenediamine] markedly attenuates the anticonvulsant action of conventional antiepileptic drugs in experimental animal models of epilepsy and evokes severe seizure activity in patients treated with this methylxanthine. The objective of this study was to determine the influence of acute (single) and chronic (twice daily for 14 consecutive days) treatments with aminophylline on the anticonvulsant potential of gabapentin (a second-generation antiepileptic drug) in the mouse maximal electroshock seizure threshold model. Additionally, the effects of acute and chronic administration of aminophylline on the adverse effect potential of gabapentin in terms of motor coordination impairment were assessed in the chimney test. To evaluate pharmacokinetic characteristics of interaction between drugs, total brain concentrations of gabapentin and theophylline were estimated with high-pressure liquid chromatography and fluorescence polarization immunoassay, respectively. Results indicated that gabapentin (at doses of 75 and 100 mg/kg, i.p.) increased the threshold for electroconvulsions in mice. Aminophylline in non-convulsive doses of 50 and 100 mg/kg (i.p.), both in acute and chronic experiments, did not attenuate the anticonvulsant potential of gabapentin in the maximal electroshock seizure threshold test in mice. Similarly, aminophylline at a dose of 100 mg/kg had no impact on the adverse effect potential of gabapentin in the chimney test. Pharmacokinetic evaluation of total brain concentrations of gabapentin and theophylline revealed no significant changes in total brain concentrations of the drugs after both, acute and chronic applications of aminophylline in combination with gabapentin. The data show that aminophylline did not alter the ability of gabapentin to protect mice against seizures induced by electroconvulsive shock. The observed interaction between gabapentin and aminophylline in both acute and chronic experiments was pharmacodynamic in nature.
越来越多的证据表明,氨茶碱[茶碱(2)×乙二胺]在癫痫实验动物模型中显著减弱传统抗癫痫药物的抗惊厥作用,并在接受这种甲基黄嘌呤治疗的患者中引发严重的癫痫活动。本研究的目的是确定在小鼠最大电休克惊厥阈值模型中,急性(单次)和慢性(连续14天每日两次)给予氨茶碱对加巴喷丁(第二代抗癫痫药物)抗惊厥潜力的影响。此外,在烟囱试验中评估了急性和慢性给予氨茶碱对加巴喷丁运动协调障碍方面不良反应潜力的影响。为了评估药物之间相互作用的药代动力学特征,分别用高压液相色谱法和荧光偏振免疫分析法估计加巴喷丁和茶碱的全脑浓度。结果表明,加巴喷丁(腹腔注射剂量为75和100mg/kg)提高了小鼠电惊厥的阈值。在急性和慢性实验中,非惊厥剂量50和100mg/kg(腹腔注射)的氨茶碱均未减弱加巴喷丁在小鼠最大电休克惊厥阈值试验中的抗惊厥潜力。同样,100mg/kg剂量的氨茶碱对加巴喷丁在烟囱试验中的不良反应潜力没有影响。对加巴喷丁和茶碱全脑浓度的药代动力学评估显示,在急性和慢性联合应用氨茶碱和加巴喷丁后,药物的全脑浓度没有显著变化。数据表明,氨茶碱不会改变加巴喷丁保护小鼠免受电惊厥休克诱导的癫痫发作的能力。在急性和慢性实验中观察到的加巴喷丁和氨茶碱之间的相互作用本质上是药效学的。